Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI
3BL Media
MAY 6, 2024
Under the terms of a definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides anatomic and digital pathology laboratory services. SECAUCUS, N.J. The transaction is expected to be completed in the second quarter of 2024.
Let's personalize your content